Form 4: Teladoc Health's Chief Medical Officer Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Vidya Raman-Tangella, Chief Medical Officer of Teladoc Health, sold 468 shares of common stock at $7.26 per share on September 4, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On September 4, 2024, Vidya Raman-Tangella, the Chief Medical Officer of Teladoc Health, sold 468 shares of the company's common stock.
- The sale was executed at a price of $7.26 per share.
- This transaction was conducted under a Rule 10b5-1 trading plan adopted by Raman-Tangella on March 1, 2024.
- Following the transaction, Raman-Tangella directly owns 33,665 shares of Teladoc Health common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
Insider trading activity is always closely watched by investors. Sales by top executives can sometimes raise concerns, but pre-planned sales under 10b5-1 plans are common and often seen as less indicative of the executive's view of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 2024-03-01 | Date of adoption of Rule 10b5-1 trading plan by the reporting person. |
| 2024-09-04 | Date of the transaction: sale of 468 shares of common stock. |
| 2024-09-05 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.